Role of corticosteroids in Functional Endoscopic Sinus Surgery - a systematic review and meta-analysis

Pundir, Vishal and Pundir, Jyotsna and Lancaster, Gillian Ann and Baer, S. and Kirkland, P. and Cornet, M. and Lourijsen, E. S. and Gerogalas, C. and Fokkens, W. J. (2016) Role of corticosteroids in Functional Endoscopic Sinus Surgery - a systematic review and meta-analysis. Rhinology, 54 (1). pp. 3-19. ISSN 0300-0729

PDF (Role of Corticosteroids in Functional Endoscopic Sinus Surgery - A Systematic Review and Meta-Analysis accepted)
Role_of_Corticosteroids_in_Functional_Endoscopic_Sinus_Surgery_A_Systematic_Review_and_Meta_Analysis_accepted.pdf - Accepted Version

Download (440kB)


Background: The aim of our study is to systematically review the existing evidence on the role of corticosteroids in patients undergoing functional endoscopic sinus surgery (FESS).  Methodology: Systematic search of MEDLINE (1950- 2014), EMBASE (1980-2014), metaRegister, Cochrane Library and ISI conference proceedings was carried out.  Results: Eighteen randomised controlled trials with 1309 patients were included. Use of local and/or systemic corticosteroids with FESS was reported in four categories; operative, anaesthesia related, post-operative outcomes and risk of recurrence. Metaanalysis for operative outcomes demonstrated that, mean operative time (MD -10.70 minutes; 95% CI -15.86, -5.55; P <0.0001) and mean estimated blood loss (MD -28.32 mls; 95% CI -40.93, -15.72; P <0.0001) was significantly lower; and surgical field quality (MD -0.81; 95% CI -1.32, -0.30; P = 0.002) was significantly better in corticosteroid group. Meta-analysis showed that post-operative endoscopic scores (SMD -0.39; 95% CI -0.60, -0.17; P = 0.0004) were significantly better in corticosteroid group compared to no corticosteroid group. There was no increase in risk of sinusitis (RR 0.64; 95% CI 0.32, 1.30; P = 0.22) between use of corticosteroids and no corticosteroids; There was no significant difference in recurrence risk of chronic rhinosinusitis (CRS) in mixed population studies (RR 0.77; 95% CI 0.35, 1.70; P = 0.52) between the two groups but analysis of studies reporting on chronic rhinosinusitis with nasal polyps (CRSwNP) (RR 0.64;95% CI 0.45,0.91;P=0.01) showed significant difference in favour of the corticosteroid group.  Conclusion: Pre-operative use of local and/or systemic corticosteroids in FESS, results in significantly reduced blood loss, shorter operative time and improved surgical field quality. Studies are limited on the intra-operative use of corticosteroids to reduce postoperative pain. Postoperative corticosteroids improve postoperative endoscopic scores in CRS and recurrence rates in cases of CRSwNP.

Item Type:
Journal Article
Journal or Publication Title:
Uncontrolled Keywords:
ID Code:
Deposited By:
Deposited On:
10 May 2016 13:36
Last Modified:
09 Aug 2022 00:07